Patents by Inventor Ashok Chopra

Ashok Chopra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11851464
    Abstract: Certain embodiments are directed to NEIL2 compositions and method of using NEIL2 composition to treat subjects in need of such treatment.
    Type: Grant
    Filed: April 11, 2022
    Date of Patent: December 26, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Tapas Hazra, Sanjiv Sur, Ashok Chopra
  • Publication number: 20220259274
    Abstract: Certain embodiments are directed to NEIL2 compositions and method of using NEIL2 composition to treat subjects in need of such treatment.
    Type: Application
    Filed: April 11, 2022
    Publication date: August 18, 2022
    Inventors: Tapas HAZRA, Sanjiv SUR, Ashok CHOPRA
  • Publication number: 20200102358
    Abstract: Certain embodiments are directed to NEIL2 compositions and method of using NEIL2 composition to treat subjects in need of such treatment.
    Type: Application
    Filed: September 27, 2019
    Publication date: April 2, 2020
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Tapas HAZRA, Sanjiv SUR, Ashok CHOPRA
  • Publication number: 20190092827
    Abstract: The present invention includes composition and methods of using a recombinant dimeric chemokine covalently modified by introducing a disulfide bond across a dimer interface, wherein the recombinant dimeric chemokine is linked by an intermolecular disulfide bond.
    Type: Application
    Filed: September 26, 2018
    Publication date: March 28, 2019
    Applicant: Board of Regents, The University of Texas System
    Inventors: Krishna Rajarathnam, Ashok Chopra
  • Patent number: 7655241
    Abstract: The present invention concerns the use of methods and compositions to prophylactically or therapeutically vaccinate a subject against a pathogen or disease. Embodiments of the invention include the production of an attenuated bacterium from the family Enterobacteriaceae with a non-functional lipoprotein for use as a vaccine or as a vaccine vector for delivering antigens to a subject to be vaccinated. In certain embodiments, a bacterium of the Enterobacteriaceae family lacking a wild type LP, for example Salmonella typhimurium lacking a wild type LP, may be produced and used as a vaccine or vaccine vector.
    Type: Grant
    Filed: March 20, 2003
    Date of Patent: February 2, 2010
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Gary R. Klimpel, David W. Niesel, Ashok Chopra, Jian Sha
  • Publication number: 20030215464
    Abstract: The present invention concerns the use of methods and compositions to prophylactically or therapeutically vaccinate a subject against a pathogen or disease. Embodiments of the invention include the production of an attenuated bacterium from the family Enterobacteriaceae with a non-functional lipoprotein for use as a vaccine or as a vaccine vector for delivering antigens to a subject to be vaccinated. In certain embodiments, a bacterium of the Enterobacteriaceae family lacking a wild type LP, for example Salmonella typhimurium lacking a wild type LP, may be produced and used as a vaccine or vaccine vector.
    Type: Application
    Filed: March 20, 2003
    Publication date: November 20, 2003
    Inventors: Gary R. Klimpel, David W. Niesel, Ashok Chopra, Jian Sha